Events

« All Events

The Secret Batch Happy Hour

December 10 @ 5:00 pm - 8:00 pm

Join us at for an exclusive evening at The Secret Batch Happy Hour!

December 10, 2025

5:00 PM – 8:00 PM

San Diego Area

Further Details Coming Soon!

 

Step into the hidden world of a speakeasy-style experience you won’t forget.

Indulge in craft cocktails, great company, and a dash of mystery. Seats are limited, and entry requires a secret code provided upon RSVP—so secure your spot now and prepare to unlock the door to an unforgettable night.

 

 

 

Why Meet with Avid Bioservices?

• 30+ years of biologics development experience
• Flexible CDMO services from clinical to commercial production
• Unparalleled quality and operational excellence
• Best-in-class U.S.-based facilities
• We approach every customer and molecule with personalized care
• Onshoring with a U.S.-based CDMO reduces supply chain risks and helps navigate global tariffs

 

Meet Our Experts

Our team will be onsite to discuss:

• Process development and scale-up for biologics
• Upstream and downstream optimization strategies
• Analytical characterization and QC for complex biologics
• CGMP manufacturing for clinical and commercial supply
• How onshoring can enhance supply chain resilience and reduce geopolitical risk

 

 

Add to calendar

• Google Calendar
• iCalendar
• Outlook 365
• Outlook Live

Details

Date:

December 10

Time:

5:00 pm - 8:00 pm

Event Category:

Conference

Venue

San Diego Area

San Diego, CA United States

Related Events

• 

  JP Morgan Healthcare Conference 2026

  January 12, 2026 - January 15, 2026

News

• Avid Bioservices appoints Dave Stewart as Chief Technology and Transformation Officer

  October 7, 2025

  The newly created role marks a major step in CEO Kenneth Bilenberg’s vision to scale Avid for its next chapter of growth.    TUSTIN, Calif., November 10, 2025 – Avid […]

  Read more

• Avid Bioservices Welcomes Kenneth Bilenberg as New CEO

  September 15, 2025

  Tustin, CA, USA – September 15, 2025 – Avid Bioservices, Inc., a leading biologics contract development and manufacturing organization (CDMO), today announced the appointment of Kenneth Bilenberg as its new […]

  Read more

• CHO Plus Enters into Project Agreement with BARDA’s BioMaP Consortium to Develop High Productivity Cell Lines for Filovirus Monoclonal Antibody Production

  August 5, 2025

  SOUTH SAN FRANCISCO, California – August 05, 2025 – Privately held CHO Plus, Inc. announced today a project agreement awarded from the Biomedical Advanced Research and Development Authority’s (BARDA) Biopharmaceutical […]

  Read more

• GHO & Ampersand Complete Acquisition of Avid Bioservices

  February 5, 2025

  Download PDF Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners Acquisition of biologics Contract Development and Manufacturing Organisation Avid Bioservices now completed GHO […]

  Read more

• Avid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger

  February 5, 2025

  Download PDFAvid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger TUSTIN, Calif., February 5, 2025 — Avid […]

  Read more

• Avid Stockholders Approve Transaction with GHO and Ampersand

  January 30, 2025

  Download PDFTUSTIN, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve […]

  Read more

< View Older News